ABOUT US
QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. Our products serve a wide range of applications, including cell and gene therapy. In this space, customers can find solutions for precise determination of plasmid quality, viral titer, vector copy number and robust contaminant testing. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. Together, we are making improvements in life possible.
FEATURED ARTICLES
-
![GettyImages-2194013542-scientists-smiling-in-lab-discussing]( "Advancements In Gene Therapy Development")
Gene therapy is transforming treatment for genetic disorders. With over 30 FDA-approved therapies, gain expert insight into how digital PCR enhances AAV vector precision, safety, and regulatory compliance in development.
-
![GettyImages-1224202684-laboratory-dna-scientist-research-monitoring]( "Direct Quantification Of Residual Host Cell DNA")
Residual host cell DNA monitoring is vital in biologics manufacturing. Learn how digital PCR offers unmatched sensitivity and precision to ensure compliance with strict safety standards set by global regulatory agencies.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "A Duplex Assay For Quantification And Qualification Of AAV")
Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.
-
![GettyImages-1595648709-pipette-laboratory-assay-cell-culture]( "Quantification And Qualification Of Adeno-Associated Virus")
Explore how digital PCR technologies offer precise, reproducible AAV quantification to address qPCR limitations with streamlined workflows and dedicated CGT assays to support safe, consistent gene therapy development.
-
![GettyImages-1165637777 DNA]( "Analysis Of DNA Integrity And Stability Using Digital PCR")
Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.
-
![GettyImages-2186951197-mycoplasma-microscopic-cell]( "High-Quality Detection Of Mycoplasma Contamination")
Ensure biopharmaceutical safety with a validated RT-dPCR workflow for mycoplasma detection. Learn how Mycoplasma Standard CFU Kits support compliance and robust contamination testing across diverse sample types.
CONTACT INFORMATION
QIAGEN
QIAGEN Strasse 1
Hilden, 40724
GERMANY
Contact: https://www.qiagen.com/us/contact-us
FEATURED WEBINARS
-
![Advancements In Genome Integrity Assessment For Vector-Based Gene Therapies]( "Advancements In Genome Integrity Assessment For Gene Therapies")
Gene therapy holds promise for treating various genetic diseases. Explore the latest in gene therapy with expert insights on AAV vector integrity, dPCR-based solutions, assay design, and reference standards.
-
![Triplex RT-dPCR Method For A Safety Study In Drug Development]( "Triplex RT-dPCR Method For A Safety Study In Drug Development")
Discover how an innovative technology harnesses natural RNA editing with EONs and digital PCR to precisely correct mutations, which offers a novel approach to treating genetic diseases.
-
![Enhancing Preclinical Research Precision]( "Analyzing CAR-T Biodistribution With Digital PCR (dPCR)")
Explore a novel dPCR workflow for tracking CAR-T and leukemia cell biodistribution in rodents that enhances precision, sensitivity, and reliability in preclinical assessments of investigational cell therapies.
